XOPENEX HFA® (levalbuterol tartrate) Inhalation Aerosol
XOPENEX HFA Inhalation Aerosol: Ready-when-needed relief
XOPENEX HFA® (levalbuterol tartrate) Inhalation Aerosol is a quick-relief medicine that is used to treat the narrowing of airways (bronchospasm) caused by asthma and chronic obstructive pulmonary disease (COPD). It is taken when needed to relax the tightened muscles around the airway passages and relieve symptoms like wheezing, coughing, chest tightness, and shortness of breath. Based on clinical studies, typical response time was 4.5 minutes for pediatric patients (>4 years of age) and 5.5 to 10.2 minutes in adults (>18 years of age). If you have asthma or COPD, you should talk to your healthcare provider about whether XOPENEX HFA is right for you.
XOPENEX HFA is a handheld inhaler that is sometimes called a "puffer." It is a convenient treatment option that may help those who are unable to use a nebulizer and need quick relief from asthma symptoms. The XOPENEX HFA inhaler/puffer is designed to release a measured amount of medicine with every puff, and is indicated for children four years of age and older.
Refill before you reach 80 or 200 sprays.
Discard your XOPENEX HFA inhaler after you have used either 200 inhalations from the 15 g canister or 80 inhalations from the 8.4 g canister. The correct amount of medicine in each inhalation cannot be assured after 200 sprays from the 15 g canister or 80 sprays from the 8.4 g canister, even though the canister is not completely empty. Never immerse the canister in water to determine how full the canister is. Before you reach 80 or 200 sprays, you should consult your healthcare provider to determine if a refill is needed. Do not stop taking your XOPENEX HFA inhaler without consulting with your healthcare provider.
XOPENEX HFA® (levalbuterol tartrate) Inhalation Aerosol is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children 4 years of age and older with reversible obstructive airway disease.